Christopher C. Caillouet

Array ( [id] => 928629 [patent_doc_number] => 07314939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => 'Compositions and methods for inhibiting TGF-β' [patent_app_type] => utility [patent_app_number] => 10/869321 [patent_app_country] => US [patent_app_date] => 2004-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14438 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314939.pdf [firstpage_image] =>[orig_patent_app_number] => 10869321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 449357 [patent_doc_number] => 07250516 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Phenylalanine derivatives' [patent_app_type] => utility [patent_app_number] => 10/866260 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21766 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250516.pdf [firstpage_image] =>[orig_patent_app_number] => 10866260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5690721 [patent_doc_number] => 20060150866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Use of quinaldine and naphthaline derivatives as crystallisation modifiers' [patent_app_type] => utility [patent_app_number] => 10/560039 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6350 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20060150866.pdf [firstpage_image] =>[orig_patent_app_number] => 10560039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4509134 [patent_doc_number] => 07915418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Intermediates and process for the production of optically active quinolonecarboxylic acid derivatives' [patent_app_type] => utility [patent_app_number] => 10/559499 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3688 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915418.pdf [firstpage_image] =>[orig_patent_app_number] => 10559499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 545377 [patent_doc_number] => 07169928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications' [patent_app_type] => utility [patent_app_number] => 10/856838 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33258 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169928.pdf [firstpage_image] =>[orig_patent_app_number] => 10856838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276364 [patent_doc_number] => 20040235815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Vanadium compounds for treating cancer' [patent_app_type] => new [patent_app_number] => 10/857440 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24853 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235815.pdf [firstpage_image] =>[orig_patent_app_number] => 10857440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 676638 [patent_doc_number] => 07087759 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-08 [patent_title] => 'Melanocortin receptor ligands' [patent_app_type] => utility [patent_app_number] => 10/856983 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31351 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087759.pdf [firstpage_image] =>[orig_patent_app_number] => 10856983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 425287 [patent_doc_number] => 07271270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'High affinity small molecule C5a receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/853731 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 58680 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/271/07271270.pdf [firstpage_image] =>[orig_patent_app_number] => 10853731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026465 [patent_doc_number] => 20050020503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Hepatitis C inhibitor compounds' [patent_app_type] => utility [patent_app_number] => 10/850101 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35693 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020503.pdf [firstpage_image] =>[orig_patent_app_number] => 10850101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 267260 [patent_doc_number] => 07566786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => 'Quinoline derivatives as phosphodiesterase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/557079 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39919 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566786.pdf [firstpage_image] =>[orig_patent_app_number] => 10557079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433813 [patent_doc_number] => 20040209912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Substituted isoquinoline derivatives and their use as anticonvulsants' [patent_app_type] => new [patent_app_number] => 10/847903 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22020 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209912.pdf [firstpage_image] =>[orig_patent_app_number] => 10847903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089671 [patent_doc_number] => 20050009784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Phenyl quinolines and their use as estrogenic agents' [patent_app_type] => utility [patent_app_number] => 10/846216 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27740 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009784.pdf [firstpage_image] =>[orig_patent_app_number] => 10846216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 587029 [patent_doc_number] => 07442798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => 'Autoinducer molecules and uses therefor' [patent_app_type] => utility [patent_app_number] => 10/844037 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13199 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442798.pdf [firstpage_image] =>[orig_patent_app_number] => 10844037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707927 [patent_doc_number] => 07060712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Crystalline form of aryl aniline β2 adrenergic receptor agonist' [patent_app_type] => utility [patent_app_number] => 10/841761 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12289 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060712.pdf [firstpage_image] =>[orig_patent_app_number] => 10841761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330209 [patent_doc_number] => 20040254230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Method for treating ocular hypertension' [patent_app_type] => new [patent_app_number] => 10/494775 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21990 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254230.pdf [firstpage_image] =>[orig_patent_app_number] => 10494775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754701 [patent_doc_number] => 20060223850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => '8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/554176 [patent_app_country] => US [patent_app_date] => 2004-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24805 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223850.pdf [firstpage_image] =>[orig_patent_app_number] => 10554176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5096233 [patent_doc_number] => 20070117842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Polymorph of 4-[3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6- quinolinecarboxamide and a process for the preparation of the same' [patent_app_type] => utility [patent_app_number] => 10/553927 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13559 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117842.pdf [firstpage_image] =>[orig_patent_app_number] => 10553927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688853 [patent_doc_number] => 20070105845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Quinolone derivatives' [patent_app_type] => utility [patent_app_number] => 10/551272 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15317 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105845.pdf [firstpage_image] =>[orig_patent_app_number] => 10551272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997450 [patent_doc_number] => 20050137228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Benzyl sulfonamide derivatives' [patent_app_type] => utility [patent_app_number] => 10/824456 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13404 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137228.pdf [firstpage_image] =>[orig_patent_app_number] => 10824456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 537167 [patent_doc_number] => 07176315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof, useful in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/824034 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12535 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176315.pdf [firstpage_image] =>[orig_patent_app_number] => 10824034 [rel_patent_id] =>[rel_patent_doc_number] =>)